BIBLIOGRAFIA:

1) Elsa Reyes Naranjo* HIPERPLASIA PROSTTICA BENIGNA, REVISTA

MEDICA DE COSTA RICA Y CENTROAMERICA LXX (606) 269-272, 2013
2) Alcntara Montero A. Perspectivas futuras en el tratamiento mdico de la
hiperplasia benigna de prstata. Actas Urol Esp. 2016
3) Carrero-Lpez VM, et al. Hiperplasia prosttica benigna y sntomas del tracto
urinario inferior. Revisin de las evidencias actuales. Actas Urol Esp. 2016.
4) Rubinstein E, Gueglio G, Giudice C, Tesoln P. Hiperplasia prosttica
benigna. Evid Act Pract Ambul Oct-Dic 2013; 16(4):143-151
5) P. Cruz Garca-Villaa,*, M. Schroede-Ugaldea, M. Landa Soler-Martnb y F.
Mendoza-Pea. Factores de riesgo para el desarrollo de estenosis de uretra
en pacientes operados de reseccin transuretral de prstata. Rev Mex Urol
2013;73(4):166-174
6) Roger Kirby, John Anderson, Adrian Joyce. Diagnosis of lower urinary tract
symptoms resulting from benign prostatic hyperplasia. The British Association
of Urological Surgeons. InnovAiT 2012;6 88-92
7) Humberto Condori, Ral Medina, Cesar Loza. Relacin del residuo post-
miccional, grado de trabeculacin vesical y el flujo urinario en pacientes con
hiperplasia prosttica benigna sintomtica. Rev Med Hered. 2012; 23.
8) B. Miana, A.Rodrguez-Antoln,M. Prieto, E. Pedrosa. Perfiles de gravedad
en los pacientes diagnosticados de hiperplasia prosttica benigna en
Espaa. Actas Urol Esp. 2013
9) Claus Roehrborn, Hiperplasia prosttica benigna y menor sntoma de las vas
urinarias directrices. October 2012 ,Volume 6
10) Tag Keun Yoo and Hee Ju Cho. Hiperplasia Prosttica Benigna: del
laboratorio a la clnica. Korean J Urol. 2012 March; 53(3): 139148.
11) Ahmed M. Elshal *, Ahmed R. El-Nahas, Tamer S. Barakat, Mohamed M.
Elsaadany, Ahmed S. El-Hefnawy. Transvesical open prostatectomy for
benign prostatic hyperplasia in the era of minimally invasive surgery:
Perioperative outcomes of a contemporary series. Arab Journal of Urology
(2013)
12) Mazdar A, Bedouche A, Zoughari S, [What role does botulinum toxin play in
the treatment of benign prostatic hyperplasia?], Pan Afr Med J. 2016 Aug
11;24:309.
13) Rodrigues de Carvalho TG, Pinto R, Cruz F, Silva J., Effect of
onabotulinum toxin type a intraprostatic injection on the outcome of Benign
Prostatic Hyperplasia patients refractory to medical therapy: A 2-year follow-
up study., Arch Esp Urol. 2016 Dec;69(10):719-726.
14) Albisinni S, Biaou I, Marcelis Q, New medical treatments for lower urinary
tract symptoms due to benign prostatic hyperplasia and future perspectives,
BMC Urol. 2016 Sep 15;16(1):58.
15) Ding XD, Chen HX, Xiao HQ, Treatment of Benign Prostatic Hyperplasia by
Ultrasound-Guided Botulinum Toxin Type A Injection., Cell Biochem Biophys.
2015 Nov;73(2):357-359.
16) Shim SR, Cho YJ, Shin IS, Kim JH. Efficacy and safety of botulinum
toxin injection for benign prostatic hyperplasia: a systematic review and meta-
analysis. Int Urol Nephrol. 2016 Jan;48(1):19-30.
17) Yokoyama T1, Yamamoto Y, Suzuki T, Oguma K, Nagai A. Intraprostatic
botulinum neurotoxin type a injection for benign prostatic hyperplasia:
preliminary results with a newly purified neurotoxin. Acta Med
Okayama. 2012;66(4):291-7.
18) Alam M, Zgheib J, Dalati MF, El Khoury F. Botulinum Toxin A Injection in the
Bladder Neck: A Promising Treatment for Urinary Retention. Case Rep
Urol. 2016;2016:638527.
19) Karl-Erik Andersson, Intraprostatic injections for lower urinary tract symptoms
treatment. Curr Opin Urol. 2015 Jan;25(1):12-8.
20) Hamidi Madani A, Enshaei A, Heidarzadeh A, Transurethral
intraprostatic Botulinum toxin-A injection: a novel treatment for BPH
refractory to current medical therapy in poor surgical candidates. World J Urol.
2013 Feb;31(1):235-9.